News
Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback